BioLife Solutions, Inc. (NASDAQ:BLFS) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $4.85 and last traded at $4.82, with a volume of 296,688 shares. The stock had previously closed at $4.68.

Several equities research analysts have recently issued reports on the stock. Maxim Group set a $6.00 price objective on shares of BioLife Solutions and gave the stock a “buy” rating in a research note on Friday, August 11th. Janney Montgomery Scott upgraded shares of BioLife Solutions from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $2.62 to $5.00 in a research note on Wednesday, July 5th.

The company’s market cap is $64.16 million. The stock has a 50 day moving average of $3.50 and a 200 day moving average of $2.47.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings data on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.06). BioLife Solutions had a negative return on equity of 64.98% and a negative net margin of 63.71%. The business had revenue of $2.56 million for the quarter, compared to analysts’ expectations of $2.40 million. Analysts expect that BioLife Solutions, Inc. will post ($0.24) EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “BioLife Solutions, Inc. (BLFS) Sets New 52-Week High at $4.85” was reported by Daily Political and is owned by of Daily Political. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/23/biolife-solutions-inc-blfs-sets-new-52-week-high-at-4-85.html.

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.